1800-272-662
Shopping Cart 0
countryflagAU
Login

small-cap

Surge in AconexLtd and Mesoblast Ltd

May 24, 2016 | Team Kalkine
Surge in AconexLtd and Mesoblast Ltd

Aconex Limited


ACX Details
  • Expanding business via acquisitions and boosting capital position: Aconex Limited (ASX: ACX) stock surged over 5.8% on May 23, 2016 even though there is no specific update from the group. Aconex delivered a solid operating cash flow of $4.9 million for the third quarter of 2016 and is strengthening its business by acquiring Conject Holding which is a major cloud and mobile collaboration service provider in Europe and other regions. The group raised $120 million to fund this acquisition and improve its working capital. As a result, the stock already rallied over 36.1% in the last three months (as of May 20, 2016) placing ACX at unreasonable levels.
  • Recommendation: We maintain our “Expensive” recommendation on the stock at the current price of $6.18
 
Mesoblast Limited


MSB Details
  • Funds from government: Mesoblast Limited (ASX: MSB) rallied over 7.9% on May 23, 2016 as the group updated on May 20 that they got $6.2 million from the Australian Government for Research & Development (R&D) activities in 2015 financial year. The group got funds as a part of Government's R&D Tax Incentive Program, which drives industry innovation while MSB expects to keep receiving the Australian Government funds for ongoing R&D activities undertaken during the 2016 financial year.
  • Recommendation: We maintain our “Buy” on the stock at the current price of $2.02

Income Statement (Source: Company Reports)


Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in:  BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.


Mid-Cap
Technical Analysis on One NYSE-Listed Uranium Stock- UEC
Mar 13, 2026 Team Kalkine
Small-Cap
One NASDAQ- Listed Semiconductor Stock at Resistance Level- HIMX
Mar 13, 2026 Team Kalkine
Blue-Chip
MQG Scales AUM and Private Credit Capabilities to Drive Growth
Mar 13, 2026 Team Kalkine
Small-Cap
Technical Analysis on Two ASX-Listed Stock – RAU, HRN
Mar 13, 2026 Team Kalkine
Mid-Cap
Technical Analysis on One NYSE- Listed Mining Stock- ERO
Mar 12, 2026 Team Kalkine

Past performance is not a reliable indicator of future performance.